Duprey Lauren Rusckowski
Chief Transformation Officer
Duprey Lauren Rusckowski has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Sep 16, 2026.
On the most recent filing, Duprey Lauren Rusckowski is listed as Chief Transformation Officer at TAKEDA PHARMACEUTICAL CO LTD. Inside the rolling window, Duprey Lauren Rusckowski reported no open-market purchases and 2 open-market sales totaling $1.5M in TAK. The largest disclosed transaction in the window is a sale of 47,586 TAK shares on Aug 10, 2026, worth $814K.
Companies traded
Other insiders at TAK
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.5M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Duprey Lauren Rusckowski made?
Duprey Lauren Rusckowski has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Duprey Lauren Rusckowski trade?
Duprey Lauren Rusckowski has filed SEC Form 4 disclosures for 1 company, including TAK.
When was Duprey Lauren Rusckowski's most recent SEC Form 4 filing?
Duprey Lauren Rusckowski's most recent SEC Form 4 filing on Tracefour is dated Sep 16, 2026.
What is Duprey Lauren Rusckowski's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Duprey Lauren Rusckowski is listed as Chief Transformation Officer.
What is Duprey Lauren Rusckowski's total buy and sell value in the current window?
Inside the rolling retention window, Duprey Lauren Rusckowski bought $0 and sold $1.5M based on SEC Form 4 filings.
What was Duprey Lauren Rusckowski's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 47,586 TAK shares on 2026-08-10, worth $814K, per SEC Form 4 filings.